WHO Model List

dolutegravir

International nonproprietary name (English: dolutegravir). Brand names vary by country.

Indications retained by WHO

Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified.

Listed forms and strengths

Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored)

Forms retained in the model list; presentations available in each country may differ.

General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.

Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know